|
Fertility & IVF Experts: Don't Bet All On Late Motherhood |
|
|
|
|
In the wake of a new record for becoming the world's oldest mother, fertility experts are encouraged by recent research showing that older moms are as capable of good parenting as younger women -- but are increasingly concerned about women naively postponing pregnancy till later in life. [click link for full article] |
|
Read more...
|
|
|
Calypte Supports State Of The Union Address HIV/AIDS Initiative |
|
|
|
|
Calypte Biomedical Corporation (OTC Bulletin Board: CBMC), medical diagnostic tests manufacturer for the detection of antibodies to the human immunodeficiency virus (HIV) for the professional point of care (PRO) and over the counter (OTC) segments of the market today announced its continued support for President George W. [click link for full article] |
|
Read more...
|
|
|
The New England Journal Of Medicine Publishes Two Landmark Studies Of NOXAFIL(R) (Posaconazole) In.. |
|
|
|
|
Two landmark clinical studies demonstrating the efficacy of NOXAFIL(R) (posaconazole) Oral Suspension in the prevention (prophylaxis) of life-threatening invasive fungal infections (IFIs) caused by Aspergillus and Candida in high-risk patients were published today in The New England Journal of Medicine,(1,2) reported Schering-Plough Corporation (NYSE: SGP). [click link for full article] |
|
Read more...
|
|
|
Spectrum Pharmaceuticals Initiates Phase 2b Trial For Ozarelix In Patients With Benign Prostate... |
|
|
|
|
Spectrum Pharmaceuticals, Inc. (Nasdaq: SPPI) announced today that the first patient has been dosed in the company's Phase 2b study of ozarelix in the U.S. in patients with benign prostate hypertrophy (BPH). The trial will be conducted in accordance with the protocol recently accepted by the U.S. Food and Drug Administration (FDA). [click link for full article] |
|
Read more...
|
|
|
BioCryst Initiates Phase II Influenza Clinical Trial To Evaluate Peramivir |
|
|
|
|
BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that it has initiated a Phase II clinical trial of peramivir, the company's lead influenza neuraminidase inhibitor, to determine the safety and efficacy of an intramuscular formulation of the drug in patients with influenza. [click link for full article] |
|
Read more...
|
|
|
|
<< Start < Prev 7121 7122 7123 7124 7125 7126 7127 7128 7129 7130 Next > End >>
|
| Results 64135 - 64143 of 71303 |
